INVO Bioscience, Inc. (INVO) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. on November 29, 2021. The company, incorporated in Nevada and headquartered in Sarasota, Florida, operates in the fertility technology sector. The report details a material definitive agreement entered into on the date of the report.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on a contractual agreement rather than periodic financial results.
Material Changes and Agreements
On November 29, 2021, INVO Bioscience entered into an INVOcell Supply Agreement with two Spanish entities: FIV Marbella SL ("OVO Clinic") and OVAVIT SL ("OVO Bank"). Key terms include:
- Product Sales: OVO Clinic will order INVOcell devices, which INVO will sell under the agreement's terms.
- Exclusive Rights: INVO granted OVO Clinic the exclusive right to acquire products and perform IVC Procedures within defined "OVO Regions."
- Retained Rights: INVO retained the right to sell products in defined "INVO Regions."
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard disclosure that certain confidential portions of the agreement were redacted to prevent competitive harm. The full text of the agreement is filed as Exhibit 10.1.
Investor Verification Checklist
- Review Exhibit 10.1 (INVOcell Supply Agreement) for specific definitions of "OVO Regions" and "INVO Regions" to understand the geographic scope of exclusivity.
- Verify the redacted portions of the agreement to assess if any material financial terms (e.g., minimum purchase commitments, pricing) were omitted.
- Confirm the operational status of OVO Clinic and OVO Bank to evaluate the strategic value of this partnership.
- Check subsequent filings for updates on product shipments or revenue recognition related to this agreement.